PDPN and breast cancer: Podoplanin-null mice have defects in lymphatic vessels formation, which results in diminished lymphatic transport, congenital lymphedema, and the dilation of lymphatic vessels [65]; podoplanin-positive lymphatics were showed to be rate-limiting for breast cancer metastasis [66].